Skip to main content

Novartis opens campus up for innovation

Novartis opens its campus. The first partner is Switzerland Innovation Park Basel Area
| News

Novartis opens campus up for innovation


Basel-based pharmaceutical Novartis is opening up its campus in Basel to external partners, including Switzerland Innovation Park Basel Area, which will establish an additional office there.

Novartis opens its campus. The first partner is Switzerland Innovation Park Basel Area
Building on the Novartis Campus into which the Switzerland Innovation Park Basel Area is moving (Photo: Zehnder/Novartis)

The Novartis Campus in Basel is a “city within a city”, according to an article by the Swiss broadcasting company SRF. Some 9,500 people currently work there, and the campus features restaurants and stores.

In the future, external firms and institutions will also find a home on the campus after the Basel-based pharmaceutical decided to open its campus to others.

“In today’s digital world, information can no longer be protected by fences. Everyone has access to everything from anywhere,” said Jörg Reinhardt, chairman of the board of directors of Novartis.

The first partner to benefit from this move is Switzerland Innovation Park Basel Area, which is operated by the business promotion area The innovation park will open an additional office on the Novartis Company in April, where it will establish an ideation lab on an area of 500 square meters.  The new lab will offer space for startups to collaborate with Novartis on innovation.

Christof Klöpper, CEO of the Switzerland Innovation Park Basel Area, said in the television programme “Schweiz aktuell“: “For us it is a unique opportunity to be present on the Novartis Campus.  With the additional site of the Switzerland Innovation Park Basel Area we want to give startups, academic groups and companies access to Novartis researchers.  On the Campus we will create an ideation lab to promote innovation.”

A second partner ov Novartis has already been found in the Friedrich Miescher Institute (FMI), which will move into the Novartis Campus in 2023. The building is still under construction.

Novartis also plans to build a new visitor center on the site at a cost of CHF 20 million, which will feature an exhibition about the pharmaceutical company as well as space for hosting events. “We will explain, for instance, how a drug is developed or what gene therapy is,” Reinhardt explained.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.